Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Progression02:07

Tumor Progression

6.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K
Tumor Progression02:07

Tumor Progression

3.1K
3.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.0K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

1.4K
1.4K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

2.6K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
2.6K
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

1.1K
1.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Contemporary indications and outcomes of open surgical cerebral aneurysm management in the endovascular era.

Frontiers in surgery·2026
Same author

Advancing Cranioplasty Techniques Through Exoscopic Magnification: A Case-Series and Single-Center Experience.

Operative neurosurgery (Hagerstown, Md.)·2026
Same author

Drip-and-Ship versus Mothership Model in Acute Ischemic Stroke: A Meta-Analysis Stratified by Stroke System Integration.

The Journal of emergency medicine·2026
Same author

Commentary: Surgical Management of Optic Pathway-Hypothalamic Gliomas: Institutional Experience and Systematic Review.

Operative neurosurgery (Hagerstown, Md.)·2026
Same author

Commentary: Magnetic Resonance Venography-Based Anterior Interhemispheric Transcallosal-Transforaminal Approach to Colloid Cysts of the Third Ventricle.

Operative neurosurgery (Hagerstown, Md.)·2026
Same author

The Influence of Dual Revascularization Techniques on Middle Meningeal Artery Collateral Networks in Moyamoya Angiopathy.

Operative neurosurgery (Hagerstown, Md.)·2026

Related Experiment Video

Updated: May 5, 2026

Preparation Of Neovascular Tissues from Human Glioma Tissues for Quantitative Proteomics Analysis of Tumor Angiogenesis
09:33

Preparation Of Neovascular Tissues from Human Glioma Tissues for Quantitative Proteomics Analysis of Tumor Angiogenesis

Published on: March 20, 2026

120

Neuro-Oncology Biotech Industry Progress Report 2025.

Zoey A Croft1, Griffin Thomas1, Evan Keister1

  • 1Neurosurgery, Lenox Hill Hospital, New York, USA.

Cureus
|May 4, 2026
PubMed
Summary

The 2025 Brain Tumor Biotech Summit showcased advancements in neuro-oncology, focusing on new treatments and drug delivery for brain tumors. Translational partnerships are crucial for accelerating therapy development for glioma patients.

Keywords:
biotechnologybrain tumorglioblastomagliomaneuro-oncology

More Related Videos

Hydrogel Arrays Enable Increased Throughput for Screening Effects of Matrix Components and Therapeutics in 3D Tumor Models
10:49

Hydrogel Arrays Enable Increased Throughput for Screening Effects of Matrix Components and Therapeutics in 3D Tumor Models

Published on: June 16, 2022

2.3K
Advancements in the Metabolic Profiling of Three-Dimensional Brain Tumor Spheroids for Drug Screening
06:50

Advancements in the Metabolic Profiling of Three-Dimensional Brain Tumor Spheroids for Drug Screening

Published on: September 5, 2025

628

Related Experiment Videos

Last Updated: May 5, 2026

Preparation Of Neovascular Tissues from Human Glioma Tissues for Quantitative Proteomics Analysis of Tumor Angiogenesis
09:33

Preparation Of Neovascular Tissues from Human Glioma Tissues for Quantitative Proteomics Analysis of Tumor Angiogenesis

Published on: March 20, 2026

120
Hydrogel Arrays Enable Increased Throughput for Screening Effects of Matrix Components and Therapeutics in 3D Tumor Models
10:49

Hydrogel Arrays Enable Increased Throughput for Screening Effects of Matrix Components and Therapeutics in 3D Tumor Models

Published on: June 16, 2022

2.3K
Advancements in the Metabolic Profiling of Three-Dimensional Brain Tumor Spheroids for Drug Screening
06:50

Advancements in the Metabolic Profiling of Three-Dimensional Brain Tumor Spheroids for Drug Screening

Published on: September 5, 2025

628

Area of Science:

  • Neuro-oncology
  • Cancer Therapeutics
  • Biotechnology

Background:

  • Neuro-oncology is a rapidly advancing field with increasing clinical trials.
  • The 2025 Brain Tumor Biotech Summit convened leaders from academia, biotech, and investment.

Purpose of the Study:

  • To summarize key discussions and advancements presented at the 2025 Brain Tumor Biotech Summit.
  • To highlight emerging treatments, novel drug delivery, and device-based therapeutics in neuro-oncology.

Main Methods:

  • The summit focused on progress in clinical trials for glioblastoma (GBM) and other CNS tumors.
  • Presentations covered early-phase technologies and personalized treatment strategies.

Main Results:

  • Recent advancements in neuro-oncology were discussed.
  • Progress on clinical trials and early-phase technologies for brain tumors was presented.

Conclusions:

  • Translational partnerships are vital for accelerating therapy development.
  • The summit emphasized the importance of collaboration in advancing treatments for glioma patients.